Innovation1 Biotech
IVBT · OTC
Price unavailable right now.
No price history for this range.
Key indicators
IVBT profitability and balance sheet ratios
Return on equity -2023.6% in May 2023.
| Period | Return on equity |
|---|---|
| Aug 2022 | -126.5% |
| Nov 2022 | -189.1% |
| Feb 2023 | -343.4% |
| May 2023 | -2023.6% |
Income statement
No financial statements are reported for Innovation1 Biotech.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Aug 2023 | Nov 2023 | Feb 2024 |
|---|---|---|---|
| Total assets | $0.1M | $0.0M | $0.1M |
| Total liabilities | $3.5M | $3.1M | $3.5M |
| Shareholder equity | −$3.4M | −$3.1M | −$3.3M |
| Cash and short-term investments | $0.0M | $0.0M | $0.1M |
| Total debt | $0.2M | $0.5M | $0.6M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.